| Dr Bradly Alain Stelter, MD | |
|
600 Highland Ave, Madison, WI 53792-0001 | |
| (608) 263-6400 | |
| Not Available |
| Full Name | Dr Bradly Alain Stelter |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Location | 600 Highland Ave, Madison, Wisconsin |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043906274 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 100169 (Wisconsin) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Bradly Alain Stelter, MD 600 Highland Ave, Madison, WI 53792-0001 Ph: () - | Dr Bradly Alain Stelter, MD 600 Highland Ave, Madison, WI 53792-0001 Ph: (608) 263-6400 |
News Archive
Nevro Corp., a medical device company that has developed and commercialized an innovative, evidence-based neuromodulation platform for the treatment of chronic pain, today announced that it has received a letter from the U.S. Food and Drug Administration informing the company of the approvability of its Premarket Approval Application (PMA) for the Senza spinal cord stimulation (SCS) system.
The bone marrow stem cells responsible for generating new blood cells are less fixed and more flexible than previously thought, according to a paper published online on February 7 in the Journal of Experimental Medicine.
Intelligent Labs a premium supplement company today announced the launch in the UK of their Ultra Pure Omega 3, after launching in the US this summer to great success. They believe their Ultra Pure Omega 3 will be the strongest and most effective Omega 3 fish oil available in the UK.
Techulon Inc., an early stage life sciences company has signed an agreement with Nacalai USA, Inc. and its parent company Nacalai Tesque, Inc. for distribution of its Glycofect Transfection Reagent platform products in Japan. Glycofect is a polymeric transfection reagent designed to be particularly effective in primary cells of therapeutic interest. It is being used by government, university and corporate laboratories around the world for advanced research towards better understanding of cell biology and for development of new cell-based therapeutics.
Researchers at Dana-Farber/Children's Hospital Cancer Center have devised a strategy to directly activate a natural "death" protein, triggering the self-destruction of cells. They say the development could represent a new paradigm for designing cancer drugs.
› Verified 8 days ago
Andrew Mark Schroeder, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 4029 Council Crst, Madison, WI 53711 Phone: 608-692-6481 | |
John Henry Norman Harrison, Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 600 Highland Ave, Madison, WI 53792 Phone: 608-263-8100 | |
Stephen H Vander Sluis, Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 700 S Park St, Madison, WI 53715 Phone: 608-251-6100 Fax: 608-258-5222 | |
Peter Gerard Pryde, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 202 S Park St, 4 Tower, Madison, WI 53715 Phone: 608-267-6676 | |
Justin Allen Lehrke, CRNA Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 700 S Park St, Madison, WI 53715 Phone: 608-251-6100 Fax: 608-258-5222 | |
Dr. Laurence Ross Rothstein, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 202 South Park Street, C/o Madison Anesthesiology Consultants, Llp, Madison, WI 53715 Phone: 608-267-6676 | |
Barbara Ann Caropreso, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 202 S Park St, Madison, WI 53715 Phone: 608-267-6676 |